Log In
Print
BCIQ
Print
Print this Print this
 

eniluracil

Also known as: ADH300004 (formerly 776C85)

  Manage Alerts
Collapse Summary General Information
Company Adherex Technologies Inc.
DescriptionDihydropyrimidine dehydrogenase inhibitor
Molecular Target Dihydropyrimidine dehydrogenase
Mechanism of ActionDihydropryimidine dehydrogenase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationBreast cancer
Indication DetailsTreat anthracycline-resistant breast cancer; Treat breast cancer; Treat metastatic breast cancer; Treat taxane-resistant breast cancer
Regulatory Designation

Partner

GlaxoSmithKline plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today